**Core Concept**
Granulomatous hepatitis refers to a condition where granulomas, aggregates of immune cells, form in the liver. This can be due to various causes, including infections, autoimmune diseases, and reactions to medications. The underlying principle involves the immune system's response to a perceived threat.

**Why the Correct Answer is Right**
The correct answer is often related to conditions that trigger a granulomatous response, such as primary biliary cirrhosis, sarcoidosis, or drug-induced liver injury. Sarcoidosis, a systemic granulomatous disease, commonly affects the lungs but can also involve the liver, leading to granulomatous hepatitis.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option text, it's challenging to provide a detailed explanation. However, incorrect options might include conditions that do not typically cause granulomatous hepatitis.
**Option B:** Similarly, without the text, it's hard to comment, but this could be a condition that affects the liver differently.
**Option C:** This might be a condition or drug that is not commonly associated with granulomatous changes in the liver.
**Option D:** Could be a disease or agent that causes liver damage through mechanisms other than granuloma formation.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that granulomatous hepatitis can present with nonspecific symptoms like fever and abdominal pain, and its diagnosis often requires liver biopsy. Sarcoidosis is a classic cause, and recognizing its systemic nature is crucial.

**Correct Answer:** D. Sarcoidosis.